PURE Bioscience, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $1.5M | $6.3M | $3.8M |
| FY2021 | $970.0K | $4.3M | $2.4M |
| FY2022 | $575.0K | $4.5M | $3.4M |
| FY2023 | $1.6M | $1.8M | $1.1M |
| FY2024 | $3.7M | $818.0K | $349.0K |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $1.5M | $6.3M | $3.8M |
| FY2021 | $970.0K | $4.3M | $2.4M |
| FY2022 | $575.0K | $4.5M | $3.4M |
| FY2023 | $1.6M | $1.8M | $1.1M |
| FY2024 | $3.7M | $818.0K | $349.0K |